The American Association of Clinical Endocrinologists and the American College of Endocrinology updated their algorithm for treatment of type 2 diabetes, while the American Diabetes Association released a position statement on management of diabetes
Metformin—including its use, effects, and mechanisms—was the focus of some research published in the past month.
The risks of cancer in patients taking medication for diabetes were analyzed by 2 recent studies.
Renal side effects of diabetes drugs were in the news in the past month, with one industry-funded study finding an association between empagliflozin and slower progression of kidney disease and the FDA strengthening an existing warning on risk of
Predicting cardiovascular events in patients with type 2 diabetes was the focus of multiple recent studies.
Several recent studies addressed the effects of diabetes and diabetes treatments on cardiovascular risk.
The risks and consequences of hypoglycemia were described by several studies published recently.
Three comparisons of bariatric surgery and medical management for obese type 2 diabetes patients were recently published in journals of the American Medical Association.
Several recent analyses of national health care data assessed the prevalence of diabetes and its complications in the U.S.
The timing of insulin injections for patients with type 2 diabetes was the focus of several studies published in the past month.